A Clinical Reminder Order Check Intervention to Improve Guideline-concordant Imaging Practices for Men With Prostate Cancer: A Pilot Study.
Evaluation Studies as Topic
Guideline Adherence
/ organization & administration
Humans
Male
Medical Order Entry Systems
/ organization & administration
Medical Overuse
/ prevention & control
Pilot Projects
Practice Guidelines as Topic
Prostate
/ diagnostic imaging
Prostatic Neoplasms
/ diagnosis
Reminder Systems
United States
Journal
Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
13
02
2020
revised:
19
04
2020
accepted:
11
05
2020
pubmed:
30
7
2020
medline:
4
2
2022
entrez:
30
7
2020
Statut:
ppublish
Résumé
To understand how to potentially improve inappropriate prostate cancer imaging rates we used National Comprehensive Cancer Network's guidelines to design and implement a Clinical Reminder Order Check (CROC) that alerts ordering providers of potentially inappropriate imaging orders in real-time based on patient features of men diagnosed with low-risk prostate cancer. We implemented the CROC at VA New York Harbor Healthcare System from April 2, 2015 to November 15, 2017. We then used VA administrative claims from the VA's Corporate Data Warehouse to analyze imaging rates among men with low-risk prostate cancer at VA New York Harbor Healthcare System before and after CROC implementation. We also collected and cataloged provider responses in response to overriding the CROC in qualitative analysis. RESULTS FIFTY SEVEN PERCENT: (117/205) of Veterans before CROC installation and 73% (61/83) of Veterans post-intervention with low-risk prostate cancer received guideline-concordant care. While the decrease in inappropriate imaging during our study window was almost certainly due to many factors, a Computerized Patient Record System-based CROC intervention is likely associated with at least moderate improvement in guideline-concordant imaging practices for Veterans with low-risk prostate cancer.
Identifiants
pubmed: 32721517
pii: S0090-4295(20)30888-8
doi: 10.1016/j.urology.2020.05.101
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
113-119Subventions
Organisme : HSRD VA
ID : IK2 HX000851
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
Published by Elsevier Inc.